Philippines Medical Device Registration Guide (2026): Complete PFDA Process, Fees, Classification & Requirements

Overview of the Philippines Medical Device Market

The Philippines is a rapidly growing medical device market in Southeast Asia with approximately $1.5 billion in annual imports. The country's healthcare expenditure continues to rise, driven by a population of over 115 million, universal healthcare reform (Universal Health Care Act), and a strong private hospital sector. The Philippines imports over 90% of its medical devices, creating substantial opportunities for international manufacturers.

Medical devices are regulated by the Center for Device Regulation, Radiation Health and Research (CDRRHR) under the Food and Drug Administration (FDA) of the Philippines, which is an attached agency of the Department of Health (DOH).

The Philippines is an ASEAN member state and has adopted the ASEAN Medical Device Directive (AMDD) classification framework through Administrative Order (AO) 2018-0002. The country accepts English-language documentation, making it one of the most accessible ASEAN markets for English-speaking manufacturers.

Regulatory Framework

Key Legislation

Regulation	Date	Purpose
Republic Act No. 9711 (FDA Act of 2009)	2009	Established the FDA as the national regulatory authority
Administrative Order 2018-0002	2018	Introduced AMDD-aligned risk classification (Class A–D), new registration and renewal requirements
Republic Act No. 11223 (Universal Health Care Act)	2019	Expanded healthcare coverage, increasing device demand
FDA Circular No. 2021-002	2021	Full AMDD implementation requirements and timelines
Draft Circular on Device Grouping	2026	Framework for grouping multiple devices under single registration
Draft Circular on Surveillance & Traceability	2026	Stricter post-market surveillance and adverse event reporting

Regulatory Authority

Center for Device Regulation, Radiation Health and Research (CDRRHR) — under the Philippines FDA (PFDA). CDRRHR handles:

• Device classification and registration
• License to Operate (LTO) issuance for importers, distributors, and manufacturers
• Post-market surveillance and vigilance
• Advertising and promotion approval
• Import clearance and customs facilitation

Device Classification

The Philippines fully adopts the ASEAN Medical Device Directive (AMDD) four-class risk-based classification system:

Class	Risk Level	Registration Type	Authorization
Class A	Low risk	Notification	Certificate of Medical Device Notification (CMDN)
Class B	Low to moderate risk	Registration	Certificate of Medical Device Registration (CMDR)
Class C	Moderate to high risk	Registration	Certificate of Medical Device Registration (CMDR)
Class D	High risk	Registration	Certificate of Medical Device Registration (CMDR)

Classification Criteria

Classification follows AMDD rules based on:

• Intended purpose and manufacturer's stated claims
• Duration of contact with the body (transient, short-term, long-term)
• Degree of invasiveness (non-invasive, body orifice, surgically invasive)
• Active nature of the device
• Software risk level (for Software as a Medical Device)

Examples by Class

Class	Examples
Class A	Non-sterile bandages, manual surgical instruments, wheelchairs
Class B	Suction pumps, infusion equipment, powered wheelchairs
Class C	Blood glucose meters, HF surgical devices, soft contact lenses, electrosurgical devices
Class D	Ventilators, implantable devices, surgical robots, cardiovascular stents

Registration Requirements

Establishment Licensing — License to Operate (LTO)

Before registering any medical device, the local entity must hold a valid License to Operate (LTO) from the PFDA. The LTO categories include:

LTO Type	Initial Fee (PHP)	Renewal Fee (PHP)
Manufacturer (revenue ≤ PHP 20M)	30,900	30,900
Manufacturer (revenue > PHP 20M)	50,800	50,800
Distributor (Importer/Exporter/Wholesaler) & Trader	8,500	8,500
Retailer	3,900	3,900

All fees subject to 1% Legal Research Fee (LRF).

The LTO is valid for 1 year for retailers and requires annual renewal. Importers and wholesalers must renew before expiration.

Product Registration Fees

Classification	Risk Level	Review Time	Application Fee (PHP)*
Class A (CMDN)	Low	4–12 weeks	81,000
Class B (CMDR)	Low to moderate	Within 180 days	108,000
Class C (CMDR)	Moderate to high	Within 180 days	111,000
Class D (CMDR)	High	Within 180 days	117,000

Exclusive of 1% LRF, notary, and bank fees.

Product Registration Fees (FDA Fee Schedule)

Registration Type	Initial Fee (PHP)	Renewal Fee (PHP)
Certificate of Medical Device Notification — Class A	13,500	15,300
Certificate of Medical Device Registration — Class B	18,000	15,300
Certificate of Medical Device Registration — Class C	18,500	15,300
Certificate of Medical Device Registration — Class D	19,500	15,300
CPR Reapplication	2,800	N/A
Compassionate Special Permit	1,200	N/A

All fees subject to 1% Legal Research Fee (LRF).

IVD Registration Fees

IVD Type	Initial Fee (PHP)
Class A	14,500
Class B	19,400
Class C	20,000
Class D	20,400

CMDN vs. CMDR — Understanding the Difference

Certificate of Medical Device Notification (CMDN) — Class A

• Risk level: Low
• Process: Notification and authentication
• Timeline: 4–12 weeks for authentication
• Nature: Administrative review confirming compliance with essential principles
• Renewal: Required

Certificate of Medical Device Registration (CMDR) — Class B, C, D

• Risk level: Low-moderate to high
• Process: Full registration with technical evaluation
• Timeline: Within 180 working days
• Nature: Technical assessment of safety, quality, and efficacy
• Renewal: Required

Who Can Register a Medical Device in the Philippines

Only entities with a valid LTO can register medical devices. Foreign manufacturers must work through a local Authorized Representative (AR) or Marketing Authorization Holder (MAH).

Options for Foreign Manufacturers

1. Establish a Philippine subsidiary — Register with the Securities and Exchange Commission (SEC), obtain an LTO as importer/distributor. Maximum control but requires local entity setup.

2. Appoint a local distributor as MAH — The distributor holds the CMDN/CMDR and manages regulatory compliance. Fastest option but ties registration to the distributor.

3. Appoint an independent MAH/AR — A regulatory services firm that holds registration independently from commercial distribution. Can issue Letters of Authorization to multiple distributors.

Local Authorized Representative (AR) Responsibilities

The AR must hold an LTO-Importer and is responsible for:

• Registration submission to CDRRHR
• Importation and customs clearance
• Product recall coordination and vigilance reporting
• Advertising/marketing approval
• Post-market surveillance compliance

Multiple ARs are allowed but require separate registrations. The AR is tied to the registration number.

Required Documentation

Legal Documents

• Notarized application form
• Valid LTO of the applicant
• Letter of Authorization from manufacturer (for imported devices) — must be accompanied by original notarized declaration from the legal manufacturer confirming authenticity
• ISO 13485 certificate or equivalent QMS certification
• Certificate of Free Sale (CFS) or market authorization from country of origin

Technical Documents (CSDT Format)

Document	Class A (CMDN)	Class B–D (CMDR)
Device description and intended use	Required	Required
Essential Principles checklist	Required	Required
Risk analysis (ISO 14971)	Recommended	Required
Clinical/performance evidence	Limited	Required
Labeling and IFU	Required	Required
QMS documentation	Required	Required
Biocompatibility data	If applicable	Required
Electrical safety/EMC data	If applicable	Required

Language Requirements

English is accepted for all documentation — a major advantage for international manufacturers. Labels must be in English or Filipino.

Labeling Requirements

Product labels must include:

1. English or Filipino language
2. Product name, brand name, or trade name
3. Product code/reference number
4. Net content or pack size
5. Registration number (CMDN or CMDR)
6. Manufacturer and Marketing Authorization Holder (Importer/Distributor) name and address
7. Batch/Lot code or serial number
8. Manufacture date and expiration date
9. Sterility status and method of sterilization (if applicable)
10. Warnings, precautions, and contraindications
11. Special handling or storage conditions
12. Intended use
13. Instructions for Use (if needed due to device complexity)

Step-by-Step Registration Process

Step 1 — Classify Your Device

Determine the risk class (A–D) following AMDD classification rules. The Philippines uses the same classification framework as other ASEAN member states.

Step 2 — Appoint a Local MAH/AR

If you are a foreign manufacturer, appoint a Philippine-based entity with a valid LTO to act as your MAH/AR.

Step 3 — Obtain License to Operate (LTO)

The local entity applies for and maintains a valid LTO as an importer, distributor, or trader of medical devices.

Step 4 — Prepare the CSDT Dossier

Compile the ASEAN CSDT dossier with Philippines-specific requirements. Ensure ISO 13485 certificate is current and covers the manufacturing site.

Step 5 — Submit Application

Submit through the PFDA eServices Portal / eLTO / eRegistration platform. Pay the applicable application fee.

Step 6 — CDRRHR Evaluation

• Class A: Authentication review (4–12 weeks)
• Class B–D: Technical evaluation (within 180 working days)
• If documentation is insufficient, CDRRHR requests additional data — applicant has 30 calendar days to respond
• If a second compliance request is needed, a re-application fee applies

Step 7 — Marketing Authorization Issuance

Upon successful evaluation:

• Class A: Certificate of Medical Device Notification (CMDN)
• Class B–D: Certificate of Medical Device Registration (CMDR) or Certificate of Product Registration (CPR)

Step 8 — Import and Market

Present the CMDN/CMDR during customs clearance. The MAH/AR manages the importation process.

Step 9 — Maintain Compliance

• Renew CMDN/CMDR before expiration
• Submit adverse event reports within mandated timelines
• Report field safety corrective actions
• Renew LTO annually

License Transfer

CMDN/CMDR registrations can be transferred between MAHs. Requirements include:

• Letter of request
• Termination of contract with previous MAH
• Original registration certificate
• Complete labeling file
• Foreign agency agreement
• ISO 13485 certificate

Processing time: 2–3 months.

Abridged Pathway

The Philippines offers an abridged registration pathway for devices that hold approval from recognized reference regulatory agencies (US FDA, CE marking under EU MDR, Health Canada, Australia TGA, Japan PMDA). This can reduce review time to approximately 2–4 months.

Registration Validity and Renewal

CMDN and CMDR certificates are valid for 5 years and must be renewed before expiration. Renewals can be filed 90 days prior to the expiry date. The renewal process requires updated technical documentation (if changes have been made), current ISO 13485 certificate, post-market surveillance summary, and renewal fee payment.

Failure to renew before expiration may result in the device being removed from the market until re-registration is completed.

Exceptions to Registration Requirement

Medical devices used strictly for the following purposes are exempt from notification and registration:

• Research and clinical trials
• Exhibitions and demonstrations
• Donated devices (new devices only)

Researchers and institutions using exempt devices must apply for a Certificate of Medical Device Listing from CDRRHR.

If a device is not yet on the FDA's list of registrable devices, registration is not required until the device is added to the list. Manufacturers can inquire about classification status by contacting CDRRHR at cdrrhr.lrd@fda.gov.ph.

Post-Market Surveillance (Updated 2026)

The PFDA released a draft circular on medical device surveillance and traceability in early 2026, proposing stricter requirements:

Proposed Adverse Event Reporting Timelines

Event Type	Reporting Deadline
Serious threat to public health	Within 48 hours
Death or serious deterioration in health	Within 10 days
Potential to cause death or serious deterioration if it recurs	Within 30 calendar days

Field Safety Corrective Action (FSCA) Reporting

FSCA notifications must be submitted to CDRRHR within mandated timelines once the manufacturer or MAH becomes aware of the need for corrective action.

Stakeholder Obligations

The proposed guidelines define responsibilities for:

1. Marketing Authorization Holders (MAHs) — Primary responsibility for vigilance, reporting, and corrective actions
2. Dealers (manufacturers, traders, distributors, retailers) — Record-keeping, complaint handling, and cooperation with regulatory authorities

Device Grouping (Draft 2026)

In 2026, the PFDA released for public consultation a Draft Circular on Grouping of Medical Devices in Product Registration. The proposed framework allows:

• Multiple medical devices to be grouped under a single product registration application
• Defined grouping categories for efficiency
• Maintained safety, effectiveness, and quality standards

This will significantly reduce the registration burden for manufacturers with product families or device systems.

Common Challenges and How to Avoid Them

1. Extended Timelines Due to Additional Documentation Requests

CDRRHR commonly requests additional documentation. Ensure the CSDT dossier is complete before submission. Budget extra time for potential queries (30 days per round).

2. LTO Compliance

The LTO must be current at all times. A lapsed LTO can invalidate product registrations. Set up renewal reminders well in advance.

3. Distributor Dependency

If the MAH is also the distributor, changing distributors requires a license transfer (2–3 months). Consider an independent MAH for flexibility.

4. Second Compliance Requests

If a second round of additional documentation is required, a re-application fee must be paid. Ensure complete and thorough responses to initial queries.

5. Incomplete ISO 13485 Coverage

Ensure the ISO 13485 certificate covers the exact manufacturing site listed in the application. Mismatches are a common cause of initial rejection.

Total Cost Estimate

Cost Item	Estimated Range
LTO — Distributor/Importer (annual)	PHP 8,500 (~$150)
Class A registration (CMDN)	PHP 81,000 (~$1,430)
Class B registration (CMDR)	PHP 108,000 (~$1,910)
Class C registration (CMDR)	PHP 111,000 (~$1,960)
Class D registration (CMDR)	PHP 117,000 (~$2,070)
Local MAH/AR fees (annual)	$2,000–$8,000
Regulatory consultant (dossier preparation)	$3,000–$15,000
Local testing (if required)	$2,000–$15,000
Total estimated cost per device	$7,000–$30,000

USD amounts approximate based on PHP 1 ≈ USD 0.018.

Key Takeaways

• English accepted for all submissions — no translation costs, unlike many ASEAN markets
• AMDD-aligned classification (Class A–D) — same framework as other ASEAN countries
• Abridged pathway available for devices with FDA/CE approval — reduces timeline to 2–4 months
• LTO required before any product registration — importers, distributors, and traders all need one
• CMDN for Class A, CMDR for Class B–D — different authorization types based on risk
• 30-day response window for additional documentation requests — plan for query rounds
• License transfer possible in 2–3 months — allows switching local representatives
• Draft grouping guidelines (2026) will allow multiple devices under single registration
• Draft surveillance guidelines (2026) propose 48-hour to 30-day adverse event reporting
• Plan 3–12 months for registration depending on device class and pathway

2026 Regulatory Updates

Draft Device Grouping Guidelines (2026)

The PFDA CDRRHR released for public consultation a Draft Circular on grouping criteria for medical device product registration. Once finalized, this will allow manufacturers to register multiple related devices under a single application, significantly reducing the administrative burden for product families and device systems.

Draft Surveillance and Traceability Guidelines (2026)

Proposed stricter post-market requirements include 48-hour reporting for serious public health threats, 10-day reporting for death/serious injury, and 30-day reporting for potential serious events. These align the Philippines with international vigilance standards.

IVD Classification Development

A separate Administrative Order for IVD classification is expected to be issued, providing specific regulatory requirements for in vitro diagnostic devices distinct from general medical devices.

ASEAN Regulatory Reliance

The Philippines continues to deepen ASEAN regulatory cooperation. With the Singapore–Malaysia pilot (2025) and potential Thailand reliance pathway, the Philippines may benefit from future ASEAN-wide recognition mechanisms. Philippines registration can be supported by referencing approvals from Singapore HSA and other reference agencies.

Frequently Asked Questions

How long does medical device registration take in the Philippines?

Class A (CMDN): 4–12 weeks. Class B–D (CMDR): 6–9 months standard (up to 180 working days). Abridged pathway: 2–4 months for devices with FDA/CE approval. Budget 3–12 months total including preparation.

Can I use my FDA clearance or CE marking?

Yes. The Philippines recognizes FDA, CE (EU MDR), Health Canada, TGA, and PMDA approvals for the abridged pathway, which can reduce review time to 2–4 months.

Is a Certificate of Free Sale required?

Yes, a CFS or market authorization from the country of origin is required as part of the registration documentation for imported devices.

Do I need a local Authorized Representative?

Yes. Foreign manufacturers must appoint a Philippine-based MAH/AR with a valid LTO. The AR submits the application, manages importation, and handles post-market obligations.

Is ISO 13485 required?

Yes. An ISO 13485 certificate or equivalent QMS certification is required for the manufacturing facility for all device classes.

Can I transfer my registration to a new MAH?

Yes. License transfer takes approximately 2–3 months. Required documents include a letter of request, termination of contract, original CMDN/CMDR, complete labeling file, foreign agency agreement, and ISO 13485 certificate.

What language is required for submissions?

English is accepted for all documentation. Labels must be in English or Filipino.

Does the Philippines require local clinical trials?

No. Clinical data from reference countries and published literature is generally accepted. The CDRRHR may request additional data for novel or high-risk devices on a case-by-case basis.

What post-market obligations exist?

MAHs must report adverse events (proposed 48-hour to 30-day timelines under 2026 draft guidelines), conduct field safety corrective actions when needed, renew CMDN/CMDR before expiration, and maintain a valid LTO at all times.